Zang DY - Search Results

1

PRODIGY: A Phase III Study of Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 Versus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer.

Kang YK, Yook JH, Park YK, Lee JS, Kim YW, Kim JY, Ryu MH, Rha SY, Chung IJ, Kim IH, Oh SC, Park YS, Son T, Jung MR, Heo MH, Kim HK, Park C, Yoo CH, Choi JH, Zang DY, Jang YJ, Sul JY, Kim JG, Kim BS, Beom SH, Cho SH, Ryu SW, Kook MC, Ryoo BY, Kim HK, Yoo MW, Lee NS, Lee SH, Kim G, Lee Y, Lee JH, Noh SH. Kang YK, et al. Among authors: zang dy. J Clin Oncol. 2021 Sep 10;39(26):2903-2913. doi: 10.1200/JCO.20.02914. Epub 2021 Jun 16. J Clin Oncol. 2021. PMID: 34133211 Free PMC article. Clinical Trial.

2

Veno-occlusive disease (VOD) of the liver in Korean patients following allogeneic bone marrow transplantation (BMT): efficacy of recombinant human tissue plasminogen activator (rt-PA) treatment.

Lee JH, Lee KH, Choi JS, Zang DY, Kim SB, Kim SW, Suh C, Lee JS, Kim WK, Lee YS, Kim SH. Lee JH, et al. Among authors: zang dy. J Korean Med Sci. 1996 Apr;11(2):118-26. doi: 10.3346/jkms.1996.11.2.118. J Korean Med Sci. 1996. PMID: 8835758 Free PMC article.

3

A randomized trial comparing cisplatin plus 5-fluorouracil with or without levamisole in operable gastric cancer.

Choi JS, Lee KH, Ahn MJ, Lee JS, Lee JH, Zang DY, Suh CW, Kim SW, Kim WG, Kim JC, Kim SK, Park KC, Lee MS, Kim SH. Choi JS, et al. Among authors: zang dy. Korean J Intern Med. 1997 Jun;12(2):155-62. doi: 10.3904/kjim.1997.12.2.155. Korean J Intern Med. 1997. PMID: 9439150 Free PMC article. Clinical Trial.

4

Phase II trial of a novel platinum analog, SKI 2053R, in patients with previously untreated extensive-stage small-cell lung cancer.

Zang DY, Lee KH, Lee JS, Lee JH, Kim WK, Kim SH, Kim WD, Kim DS, Kim JH, Kim BS, Cho YB, Kim DK, Kim KH. Zang DY, et al. Am J Clin Oncol. 1999 Oct;22(5):495-8. doi: 10.1097/00000421-199910000-00015. Am J Clin Oncol. 1999. PMID: 10521066 Clinical Trial.

5

Multicenter phase II study of oral capecitabine plus irinotecan as first-line chemotherapy in advanced colorectal cancer: a Korean Cancer Study Group trial.

Kim TW, Kang WK, Chang HM, Park JO, Ryoo BY, Ahn JS, Zang DY, Lee KH, Kang YK, Kim SR, Kim HK; Korean Cancer Study Group. Kim TW, et al. Among authors: zang dy. Acta Oncol. 2005;44(3):230-5. doi: 10.1080/02841860510029590. Acta Oncol. 2005. PMID: 16076694 Clinical Trial.

6

A phase II study with gemcitabine and split-dose cisplatin in patients with advanced non-small cell lung cancer.

Kim JH, Lee DH, Shin HC, Kwon JH, Jung JY, Kim HJ, Song HH, Lee KS, Zang DY, Ahn JS, Park YL, Lee JA. Kim JH, et al. Among authors: zang dy. Lung Cancer. 2006 Oct;54(1):57-62. doi: 10.1016/j.lungcan.2006.06.013. Epub 2006 Aug 1. Lung Cancer. 2006. PMID: 16884818 Clinical Trial.

7

Phase I/II trial with docetaxel and S-1 for patients with advanced or recurrent gastric cancer with consideration to age.

Zang DY, Yang DH, Lee HW, Hwang SW, Song HH, Jung JY, Kwon JH, Kim HJ, Kim JH, Park SR, Kim MJ, Jang KM, Park CK, Kim JH, Lee BH. Zang DY, et al. Cancer Chemother Pharmacol. 2009 Feb;63(3):509-16. doi: 10.1007/s00280-008-0768-9. Epub 2008 May 15. Cancer Chemother Pharmacol. 2009. PMID: 18481067 Clinical Trial.

8

A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.

Lee JL, Kang YK, Kang HJ, Lee KH, Zang DY, Ryoo BY, Kim JG, Park SR, Kang WK, Shin DB, Ryu MH, Chang HM, Kim TW, Baek JH, Min YJ. Lee JL, et al. Among authors: zang dy. Br J Cancer. 2008 Aug 19;99(4):584-90. doi: 10.1038/sj.bjc.6604536. Epub 2008 Jul 29. Br J Cancer. 2008. PMID: 18665164 Free PMC article. Clinical Trial.

9

Gemcitabine and oxaliplatin combination as first-line treatment for advanced pancreatic cancer: a multicenter phase II study.

Lee KH, Kim MK, Kim YH, Ryoo BY, Lim HY, Song HS, Kim HK, Lee MA, Im SA, Chang HM, Cho JY, Zang DY, Kim BS, Kim JS. Lee KH, et al. Among authors: zang dy. Cancer Chemother Pharmacol. 2009 Jul;64(2):317-25. doi: 10.1007/s00280-008-0873-9. Epub 2008 Nov 26. Cancer Chemother Pharmacol. 2009. PMID: 19034448 Clinical Trial.

10

Phase II study of the paclitaxel, cisplatin, 5-fluorouracil and leucovorin (TPFL) regimen in the treatment of advanced or metastatic gastric cancer.

Jung JY, Kwon JH, Kim JH, Song HH, Kim I, Lee KS, Kim HJ, Zang DY, Ahn JS, Lee JA, Park YI. Jung JY, et al. Among authors: zang dy. Oncol Rep. 2009 Feb;21(2):523-9. Oncol Rep. 2009. PMID: 19148531 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

164 results

Search Page